FDA Warning Letter — Sunrise Pharmaceutical, Inc.

Case 77504 — FEI 3004813394

The FDA took a Warning Letter action against Sunrise Pharmaceutical, Inc. on Jan 14, 2010 (Rahway, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Sunrise Pharmaceutical, Inc.
Date
Jan 14, 2010
Fiscal Year
2010
Product Type
Drugs
Center
CDER
Location
Rahway, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.